1. Home
  2. ALLO vs PLAY Comparison

ALLO vs PLAY Comparison

Compare ALLO & PLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allogene Therapeutics Inc.

ALLO

Allogene Therapeutics Inc.

HOLD

Current Price

$2.57

Market Cap

539.4M

Sector

Health Care

ML Signal

HOLD

Logo Dave & Buster's Entertainment Inc.

PLAY

Dave & Buster's Entertainment Inc.

HOLD

Current Price

$12.48

Market Cap

484.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLO
PLAY
Founded
2017
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
539.4M
484.5M
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
ALLO
PLAY
Price
$2.57
$12.48
Analyst Decision
Buy
Buy
Analyst Count
11
7
Target Price
$8.40
$25.29
AVG Volume (30 Days)
4.5M
1.6M
Earning Date
05-12-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
34.09
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.89
Revenue Next Year
$140,929.80
$4.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$9.61
52 Week High
$2.80
$35.38

Technical Indicators

Market Signals
Indicator
ALLO
PLAY
Relative Strength Index (RSI) 57.54 46.68
Support Level $2.14 N/A
Resistance Level $2.71 $13.92
Average True Range (ATR) 0.24 0.97
MACD -0.01 0.01
Stochastic Oscillator 75.00 66.24

Price Performance

Historical Comparison
ALLO
PLAY

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About PLAY Dave & Buster's Entertainment Inc.

Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.

Share on Social Networks: